Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05LPK
|
|||
Former ID |
DNC011968
|
|||
Drug Name |
5-Methyl-oxazolidin-(2Z)-ylideneamine
|
|||
Synonyms |
CHEMBL107413; 5-Methyl-oxazolidin-(2Z)-ylideneamine; 2-imino-5-methyloxazolidine; 5-Methyl-2-iminooxazolidine; SCHEMBL8968765; SCHEMBL6592796; BDBM50138201; AKOS006350070; AKOS013498557; 5-methyl-4,5-dihydro-oxazol-2-ylamine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C4H8N2O
|
|||
Canonical SMILES |
CC1CN=C(O1)N
|
|||
InChI |
1S/C4H8N2O/c1-3-2-6-4(5)7-3/h3H,2H2,1H3,(H2,5,6)
|
|||
InChIKey |
ZHFKVNRMZIOKGZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):313-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.